Medical equipment: Difference between revisions

Line 31:

===The Glaukos (formerly Avedro) 1st Gen KXL system===

Glaukos has announced that they're discontinuing support for their first generation KXL (crosslinking) system. The current system requires a RFID card that costs around $5000 per use of the machine. The new cost for RFID cards per use for the next generation of KXL system will be $75,000 per use ($150,000 for both eyes). This has forced all but one ophthalmology practice to drop crosslinking as a service as the cost cannot and should not be pushed to the patient. Insurance companies most likely wont cover the service for such a high cost. Crosslinking serves to treat keratoconus which is a progressive disease that leads to blindness in young people if left untreated.

Glaukos has announced that they're discontinuing support for their first generation KXL (crosslinking) system. The current system requires a RFID card that costs around $5000 per use of the machine. The new cost for RFID cards per use for the next generation of KXL system will be $75,000 per use ($150,000 for both eyes). This has forced all but one ophthalmology practice in Arizona to drop crosslinking as a service as the cost cannot and should not be pushed to the patient. Insurance companies most likely wont cover the service for such a high cost. Crosslinking serves to treat keratoconus which is a progressive disease that leads to blindness in young people if left untreated.

===Terumo Cardiovascular restricts equipment repairs===

@@ Line 31: / Line 31: @@
 ===The Glaukos (formerly Avedro) 1st Gen KXL system===
-Glaukos has announced that they're discontinuing support for their first generation KXL (crosslinking) system. The current system requires a RFID card that costs around $5000 per use of the machine. The new cost for RFID cards per use for the next generation of KXL system will be $75,000 per use ($150,000 for both eyes). This has forced all but one ophthalmology practice to drop crosslinking as a service as the cost cannot and should not be pushed to the patient. Insurance companies most likely wont cover the service for such a high cost. Crosslinking serves to treat keratoconus which is a progressive disease that leads to blindness in young people if left untreated.
+Glaukos has announced that they're discontinuing support for their first generation KXL (crosslinking) system. The current system requires a RFID card that costs around $5000 per use of the machine. The new cost for RFID cards per use for the next generation of KXL system will be $75,000 per use ($150,000 for both eyes). This has forced all but one ophthalmology practice in Arizona to drop crosslinking as a service as the cost cannot and should not be pushed to the patient. Insurance companies most likely wont cover the service for such a high cost. Crosslinking serves to treat keratoconus which is a progressive disease that leads to blindness in young people if left untreated.
 ===Terumo Cardiovascular restricts equipment repairs===